NSE / BSEHealthcare
βΉ279.25+0.15+0.05%
P/E906.0Mkt CapβΉ6.50 K CrEV/EBITDA214.8
PARK MEDI WORLD LIMITED
P/E906.0Mkt CapβΉ6.50 K CrEV/EBITDA214.8
Company Profile
Park Medi World Limited operates a network of hospitals. The company provides internal medicine, neurology, urology, gastroentereology, general surgery, orthopedics, and oncology treatment services. It operates NABH accredited multi-super specialty hospitals under the Park brand name. Park Medi World Limited was founded in 2005 and is headquartered in Gurugram, India.
Valuation
Market Cap
βΉ0.00
β
Current Price
βΉ0
βas of 15 Sept 2026
P/E Ratio
0.0x
β
P/B Ratio
β
β
EV / EBITDA
0.0x
β
EV / Sales
0.0x
β
52W High
βΉ0
β
52W Low
βΉ0
β
Shares Out
0.00 Cr
β
Profitability
Operating Margin
0.0%
β
Net Profit Margin
0.0%
β
EBITDA Margin
0.0%
β
Returns
ROE
0.0%
β
ROCE
0.0%
β
ROIC %
β
β
ROA
0.0%
β
Dividend Payout
0.0%
β
Solvency
Current Ratio
0.0x
β
Debt / Equity
0.0x
β
Debt / Assets
0.0x
β
CFO / Net Profit
0.0x
β
Interest Coverage
0.0x
β
AI Summary
Indian StockStrengths1
- Operating margin of 28.7% exceeds Healthcare median (24.8%)
Concerns1
- Low interest coverage ratio of 1.9x
Rule-based from financial data. Not advice.
Price Historyβ² 72.38% over 1Y
Monthly Returns
Year-to-Date ROI
Historical Volatility
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
RevenueβΉ91.58 Crβ² 2.3%
EBITDA GrowthββΌ 15.3%
Net ProfitβΉ7.18 CrβΌ 4.3%
Cash from Ops (CFO)ββΌ 80.7%
Free Cash Flow (FCF)ββΌ 117.5%
Revenue CAGR 5Y0.0%
EBITDA CAGR 5Y0.0%
Net Profit CAGR 5Y0.0%
NP Growth 1Y-4.3%
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 4 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | βΉ91.58 Cr | β | βΉ7.18 Cr | β | β | 6.3% | 2.3% | -4.3% |
| Mar 2024 | βΉ89.56 Cr | β | βΉ7.50 Cr | β | β | 7.0% | -12.6% | 5.5% |
| Mar 2023 | βΉ102.44 Cr | β | βΉ7.11 Cr | β | β | 7.1% | -6.8% | -14.9% |
| Mar 2022 | βΉ109.93 Cr | β | βΉ8.35 Cr | β | β | 8.5% | β | β |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Free plan Β· showing 1 year of data.Upgrade
Consolidated Figures in USD Millions.
| Unnamed: 0 | Mar 2025 |
|---|---|
| Revenue / Net Sales | 91.58 |
| Total Expenses | 67.54 |
| EBIT / Operating Profit | 24.04 |
| OPM % | 26.25% |
| Other Income | 2.07 |
| Finance Costs | 12.34 |
| Depreciation & Amortisation | 4.86 |
| Profit Before Tax | 8.91 |
| Tax % | 19.42% |
| Net Profit / PAT | 7.18 |
| EPS (βΉ) | 0.19 |
| Dividend Payout % | 0.00% |
Peer Comparison
Healthcare sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| PARK MEDI WORLD LIMITEDthis co. | βΉ6.50 K Cr | βΉ91.58 Cr | 906.00 | 0.00 | 214.83 | 2.3% |
| Sun Pharmaceutical Industries Ltd. | βΉ4.15 L Cr | βΉ23.00 K Cr | 88.70 | 17.43 | 72.30 | 13.5% |
| Divi's Laboratories Ltd. | βΉ1.71 L Cr | βΉ9.20 K Cr | 67.90 | 11.13 | 67.21 | 20.0% |
| Torrent Pharmaceuticals Ltd. | βΉ1.33 L Cr | βΉ9.68 K Cr | 62.50 | 15.76 | 45.64 | 13.5% |
| Cipla Ltd. | βΉ1.17 L Cr | βΉ19.05 K Cr | 22.50 | 3.51 | 19.33 | 14.9% |
| Apollo Hospitals Enterprises Ltd. | βΉ1.05 L Cr | βΉ8.20 K Cr | 75.00 | 11.28 | 54.44 | 12.8% |
| Max Healthcare Institute Limited | βΉ1.00 L Cr | βΉ2.66 K Cr | 144.00 | 11.76 | 96.84 | 13.8% |
| Industry Average | β | βΉ3.29 K Cr | 98.63 | 8.11 | 65.50 | 20.2% |